arginine vasopressin has been researched along with n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, NF; Schrier, RW | 1 |
| Brabant, G; Drews, G; Krämer, C; Krippeit-Drews, P; Mader, T; Prank, K; Schöfl, C; von zur Mühlen, A; Waring, M | 1 |
2 other study(ies) available for arginine vasopressin and n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide
| Article | Year |
|---|---|
Anti-calmodulin agents affect osmotic and angiotensin II-induced vasopressin release.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calmodulin; Culture Techniques; Hypothalamus; Imidazoles; Male; Osmolar Concentration; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Sulfonamides; Trifluoperazine | 1989 |
Ca2+/calmodulin inhibition and phospholipase C-linked Ca2+ Signaling in clonal beta-cells.
Topics: Animals; Arginine Vasopressin; Bombesin; Calcium; Calcium Channel Blockers; Calcium Signaling; Calmodulin; Cell Membrane; Cricetinae; Electric Conductivity; Glucose; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Pancreatic Neoplasms; Sulfonamides; Tumor Cells, Cultured; Type C Phospholipases | 1999 |